Hula Immune

Developer of therapeutic agents for autoimmune diseases and cancer treatment

placeChiyoda City, Tokyo, Japan calendar_todayFounded 2017 groups11 employees language hulaimmune.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace slowing. Cited 7 times.

YearFilings
20221

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital2100%
Coming soon